Clinical Trial Update: D4 Choline Breast PET/CT

View source ↗

Summary

Imperial College London reports the completion of a D4 Choline PET/CT trial in breast cancer, including HER2-negative, ER-positive, and metastatic disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• D4 Choline (deuterated choline radiotracer)

Snippet

Sponsor: Imperial College London | Conditions: HER2-negative Breast Cancer, ER Positive Breast Cancer | Status: COMPLETED